Indication:
Iron Sucrose is indicated for parenteral treatment of iron deficiency in cases where oral iron preparations cannot provide sufficient supplementation. 
This includes:
Patients who cannot tolerate oral iron therapy
Patients who cannot sufficiently absorb orally administered iron
Strength:
5ml:100mg(Fe)
10ml:200mg(Fe)
Innovator: Vifor (International) Inc.
Innovative Brand: Venofer
Has passed Consistency Evaluation
Qualification: Approved in China and the exported regions. Exported to more than 30 other countries and regions, including Europe and America.
Key selling points: 
1. First Generic Drug Approved  in China.
2. Compared to other iron supplementation methods, sucrose iron injection typically offers a lower price point.
3. Clinical trials have demonstrated a reduced incidence of side effects, particularly when compared to oral iron supplements, minimizing common gastrointestinal discomfort.
4. Broad applicability: suitable for patients undergoing long-term hemodialysis as well as those with iron deficiency anemia stemming from various causes.